In re: Entresto (sacubitril/valsartan)

Case: 23-2218 Document: 53 Page: 1 Filed: 03/06/2024

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit

______________________

In Re ENTRESTO (SACUBITRIL/VALSARTAN)

------------------------------------------------- NOVARTIS PHARMACEUTICALS CORPORATION,

Plaintiff-Appellant v. TORRENT PHARMA INC., TORRENT

PHARMACEUTICALS LTD.

Defendants-Appellees ------------------------------------------------- NOVARTIS PHARMACEUTICALS CORPORATION,

Plaintiff-Appellant v. ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS INC.,

Defendants ------------------------------------------------- NOVARTIS PHARMACEUTICALS CORPORATION,

Plaintiff-Appellant v. Case: 23-2218 Document: 53 Page: 2 Filed: 03/06/2024 2 IN RE ENTRESTO (SACUBITRIL/VALSARTAN) HETERO USA, INC., HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-III, MSN

PHARMACEUTICALS, INC., MSN LABORATORIES PRIVATE LTD., MSN LIFE SCIENCES PRIVATE

LTD., Defendants-Appellees ______________________

2023-2218, 2023-2219, 2023-2220, 2023-2221

______________________

Appeals from the United States District Court for the District of Delaware in Nos. 1:19-cv-01979-RGA, 1:19-cv- 02021-RGA, 1:19-cv-02053-RGA, and 1:20-md-02930-RGA, Judge Richard G. Andrews.

------------------------------------------------- NOVARTIS PHARMACEUTICALS CORPORATION,

Plaintiff-Appellant v. MYLAN PHARMACEUTICALS INC.,

Defendant-Appellee ______________________

2023-2260 ______________________

Appeal from the United States District Court for the Northern District of West Virginia in No. 1:19-cv-00201- TSK, Chief Judge Thomas S. Kleeh.

______________________ ORDER

Novartis Pharmaceuticals Corporation and Mylan Pharmaceuticals Inc. submit a joint stipulation to dismiss Case: 23-2218 Document: 53 Page: 3 Filed: 03/06/2024 IN RE ENTRESTO (SACUBITRIL/VALSARTAN) 3 Appeal No. 2023-2260 pursuant to Rule 42(b)(1) of the Fed- eral Rules of Appellate Procedure, agreeing that each bear its own costs with respect to Appeal No. 2023-2260.

Upon consideration thereof, IT IS ORDERED THAT: (1) Appeal No. 2023-2260 is deconsolidated from Ap- peal Nos. 2023-2218, 2023-2219, 2023-2220, and 2023- 2221, and Appeal No. 2023-2260 is dismissed. Each side shall bear its own costs regarding Appeal No. 2023-2260.

(2) The stay in Appeal Nos. 2023-2218, 2023-2219, 2023-2220, and 2023-2221 is lifted.

(3) The Clerk of Court shall transmit a copy of this or- der to the merits panel assigned to Appeal Nos. 2023-2218, 2023-2219, 2023-2220, and 2023-2221.

FOR THE COURT March 6, 2024

Date ISSUED AS A MANDATE (as to Appeal No. 2023-2260 only): March 6, 2024